Zavain Dar Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Zavain Dar is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 142,329 shares of RXRX, which is worth approximately $589,242. The most recent transaction as insider was on Jan 02, 2026, when has been sold 3,571 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K

2.57% 3M change

31.63% 12M change

Total Value Held $589,242

Zavain Dar Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	-	3,571 Added 2.45%	142,329 Class A Common Stock
Oct 01 2025	BUY Grant, award, or other acquisition	-	2,941 Added 2.08%	138,758 Class A Common Stock
Jul 01 2025	BUY Grant, award, or other acquisition	-	2,924 Added 2.11%	135,817 Class A Common Stock
Jun 18 2025	BUY Grant, award, or other acquisition	-	22,016 Added 14.21%	132,893 Class A Common Stock
Apr 01 2025	BUY Grant, award, or other acquisition	-	2,745 Added 2.42%	110,877 Class A Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	1,907 Added 1.73%	108,132 Class A Common Stock
Oct 01 2024	BUY Grant, award, or other acquisition	-	2,229 Added 2.06%	106,225 Class A Common Stock

Jul 01 2024	BUY Grant, award, or other acquisition	-	1,843 Added 1.74%	103,996 Class A Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	-	13,097 Added 11.36%	102,153 Class A Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	-	1,467 Added 1.62%	89,056 Class A Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	1,393 Added 2.46%	55,216 Class A Common Stock
Dec 14 2023	SELL Open market or private sale	$181,269 $9.0 p/Share	20,141 Reduced 27.23%	53,823 Class A Common Stock
Oct 02 2023	BUY Grant, award, or other acquisition	-	1,920 Added 2.53%	73,964 Class A Common Stock
Jul 03 2023	BUY Grant, award, or other acquisition	-	1,863 Added 2.52%	72,044 Class A Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	12,612 Added 15.23%	70,181 Class A Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	-	1,996 Added 8.13%	22,561 Class A Common Stock
Jul 08 2022	BUY Other acquisition or disposition	-	2,420 Added 10.53%	20,565 Class A Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	18,145 Added 50.0%	18,145 Class A Common Stock
Dec 07 2021	BUY Other acquisition or disposition	-	3,599 Added 50.0%	3,599 Class A Common Stock

Zavain Dar

Director

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account